Sodium 5-(3′-pyridinylmethyl)benzofuran-2-carboxylate (U-63557A), a new, selective thromboxane synthase inhibitor: Intravenous and oral pharmacokintics in dogs and correlations with thromboxane B2 production
- 1 August 1983
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 26 (2) , 311-324
- https://doi.org/10.1016/0090-6980(83)90098-9
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- THROMBOXANE SYNTHETASE INHIBITION AS ANTITHROMBOTIC STRATEGYThe Lancet, 1981
- ADMINISTRATION TO MAN OF UK-37,248-01, A SELECTIVE INHIBITOR OF THROMBOXANE SYNTHETASEThe Lancet, 1981
- Regulation of endothelial cell cyclic nucleotide metabolism by prostacyclin.Journal of Clinical Investigation, 1981
- Blood platelets do not provide endoperoxides for vascular prostacyclin productionNature, 1979
- Inhibitors of thromboxane synthase in human plateletsFEBS Letters, 1977
- Biosynthesis of thromboxanes in human platelets. I. Characterization and assay of thromboxane systhetaseBiochemical and Biophysical Research Communications, 1977
- Coronary Tone Modulation: Formation and Actions of Prostaglandins, Endoperoxides, and ThromboxanesScience, 1977
- Coronary Arterial Smooth Muscle Contraction by a Substance Released from Platelets: Evidence That It Is Thromboxane A 2Science, 1976
- Thromboxanes: Selective Biosynthesis and Distinct Biological PropertiesScience, 1976
- Dog platelets fail to aggregate when they form aggregating substances upon stimulation with arachidonic acidEuropean Journal of Pharmacology, 1976